Isochorismate Synthase (PchA), the First and Rate-limiting Enzyme in Salicylate Biosynthesis of Pseudomonas aeruginosa*

Catherine Gaille, Cornelia Reimmann, and Dieter HaasDagger

From the Institut de Microbiologie Fondamentale, Université de Lausanne, CH-1015 Lausanne, Switzerland

Received for publication, December 4, 2002, and in revised form, February 28, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In Pseudomonas aeruginosa the extracellular metabolite and siderophore pyochelin is synthesized from two major precursors, chorismate and L-cysteine via salicylate as an intermediate. The regulatory role of isochorismate synthase, the first enzyme in the pyochelin biosynthetic pathway, was studied. This enzyme is encoded by pchA, the last gene in the pchDCBA operon. The PchA protein was purified to apparent electrophoretic homogeneity from a PchA-overexpressing P. aeruginosa strain. The native enzyme was a 52-kDa monomer in solution, and its activity strictly depended on Mg2+. At pH 7.0, the optimum, a Km = 4.5 µM and a kcat = 43.1 min-1 were determined for chorismate. No feedback inhibitors or other allosteric effectors were found. The intracellular PchA concentration critically determined the rate of salicylate formation both in vitro and in vivo. In cultures grown in iron-limiting media to high cell densities, overexpression of the pchA gene resulted in overproduction of salicylate as well as in enhanced pyochelin formation. From this work and earlier studies, it is proposed that one important factor influencing the flux through the pyochelin biosynthetic pathway is the PchA concentration, which is determined at a transcriptional level, with pyochelin acting as a positive signal and iron as a negative signal.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In bacteria, biosynthetic pathways are regulated, as a rule, by their end products, which can cause feedback inhibition of early key enzymes as well as repression of some or all enzymes of the pathway (1). For example, in histidine biosynthesis of Salmonella enterica, histidine allosterically inhibits the first enzyme and represses, by an attenuation mechanism, the expression of all enzymes of the pathway (2). In arginine biosynthesis of Pseudomonas aeruginosa, arginine inhibits the first and the second enzyme and represses the sixth enzyme, involving the transcriptional regulator ArgR (3-5).

A more complicated situation arises in branched biosynthetic pathways where the end products may exert control functions at several checkpoints. For instance, in aromatic biosynthesis of P. aeruginosa (Fig. 1), tryptophan inhibits one isoenzyme carrying out the first reaction (AroA) and, in addition, inhibits the first tryptophan-specific enzyme, anthranilate synthase (TrpEG). Tyrosine causes feedback inhibition of the second AroA isoenzyme and two tyrosine-specific enzymes. Furthermore, tyrosine activates and phenylalanine inhibits one key enzyme (AroQ-PheA) in the phenylalanine biosynthetic branch (Fig. 1). Repression plays a relatively minor role in aromatic biosynthesis of P. aeruginosa and appears to be limited to three steps in the tryptophan biosynthetic branch (6-11). It is important to note that, in the examples cited, all end products are intracellular metabolites.

The question which concerns us here is whether the same general rules also apply to the bacterial production of extracellular metabolites. As an example, we will consider the siderophore pyochelin and its biosynthetic precursor salicylate (Fig. 1), which are produced and excreted by P. aeruginosa during iron limitation (12). Pyochelin synthesis starts from chorismate (13-15), a branch point intermediate in aromatic biosynthesis, and uses two molecules of L-cysteine (Fig. 1). Interestingly, pyochelin causes induction rather than repression of its biosynthetic enzymes (16). The mechanism of this autoinduction is not entirely clear but probably involves an initial interaction of pyochelin with its outer membrane receptor, FptA, followed by activation of the transcriptional regulator PchR, which turns on the transcription of the pyochelin biosynthetic operons pchDCBA and pchEFGHI (16-18). In this signal transduction pathway, the end product pyochelin is unlikely to accumulate in the cytoplasm. A similar regulatory mechanism has been observed for another siderophore of P. aeruginosa, pyoverdin (19). When cells have accumulated excess iron the Fur repressor is activated, which switches off the expression of the pyochelin and pyoverdin biosynthetic genes (15, 16, 20).

Here, we ask how the activity of the first enzyme of pyochelin biosynthesis, isochorismate synthase (ICS1; EC 5.4.99.6), is regulated. This enzyme catalyzes the conversion of chorismate to isochorismate and is the product of pchA, the last gene of the pchDCBA operon in P. aeruginosa (14, 15). The subsequent reaction is catalyzed by the pchB product, isochorismate pyruvate-lyase (21), which produces salicylate (Fig. 1). The pchA gene is strictly co-expressed with the upstream pchB gene; without pchB being present in cis no expression of pchA can be observed (14), suggesting that ICS and isochorismate pyruvate-lyase are produced in proportional amounts by the cells under all circumstances. Here, we report that purified ICS of P. aeruginosa is insensitive to end products of aromatic biosynthesis, in particular to salicylate, and that salicylate formation is determined essentially by the concentration rather than by allosteric control of the first enzyme. This also has implications for the productivity of the pyochelin biosynthetic pathway.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Aromatic pathways in P. aeruginosa and regulation of enzyme activity by end products. Data were compiled from Refs. 6-11, 14-16, 18, and 22-24. Enzyme designations are derived from the corresponding genotype symbols except for *AroQ and AroQ-PheA, which designate a periplasmic monofunctional chorismate mutase and a cytoplasmic bifunctional chorismate mutase, prephenate dehydratase, respectively. E-4-P, erythrose-4-phosphate; PEP, phosphoenolpyruvate; DAHP, 3-deoxy-D-arabino-heptulosonate 7-phosphate; HPP, 4-hydroxyphenylpyruvate. The two additional DAHP synthases involved in phenazine biosynthesis (24) are not shown. -, feedback inhibition; +, activation.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- P. aeruginosa strains PAO1 (wild type) and ADD1976 (PAO1 with the T7 RNA polymerase, chromosomally expressed from the lac promoter) (25) as well as plasmid pME3359 (PT7-pchBA) have been described previously (14). The construction of plasmid pME3395 is detailed in the legend of Fig. 2. Media and culture conditions for growth of P. aeruginosa have been given elsewhere (14-16). Sodium isochorismate, used as a reference, was a kind gift from E. W. Leistner (University of Cologne) or was prepared and purified as described previously (21). Racemic dihydroaeruginoate (Dha) and chorismate were prepared by the methods of Serino et al. (15) and Grisostomi et al. (26), respectively.

Purification of the PchA Enzyme-- Crude cell extracts were prepared from P. aeruginosa ADD1976 harboring the T7 promoter construct pME3359 (Fig. 2) and grown in 750 ml of nutrient yeast broth with isopropyl-beta -D-thiogalactopyranoside (IPTG) induction, as described for the extraction of PchB from a similar strain (25). Extracts contained ~8 mg of protein per milliliter of buffer A (50 mM potassium phosphate buffer, pH 7.5, containing 10% (v/v) glycerol and 1 mM dithiothreitol (DTT)). Crude extract (15 ml) was applied to a DEAE-Sepharose CL-6B column (1.6 × 20 cm) equilibrated with 10 volumes of buffer A. PchA was eluted by washing the column with 300 ml of buffer A at a flow rate of 1 ml/min. The fractions containing PchA (180 ml) were combined and loaded onto a column of phenyl-Sepharose CL-4B (1.6 × 10 cm) equilibrated with buffer A. Most of the contaminant proteins, including PchB, were eluted by washing the column with 200 ml of buffer A at 1 ml/min. More hydrophobic proteins were eluted with a step gradient of ethylene glycol as follows: 25% (v/v), 60 ml; 25-40% (v/v), 60 ml; and 40% (v/v), 65 ml. PchA was eluted with about 40 ml of 40% (v/v) ethylene glycol. This fraction was diluted five times, resulting in a buffer of 10 mM potassium phosphate, 8% (v/v) ethylene glycol, 2% (v/v) glycerol, and 1 mM DTT, and it was loaded onto a MonoQ HR 5/5 column (fast protein liquid chromatography) equilibrated with modified buffer A containing 10 mM potassium phosphate. PchA was eluted by washing the column with standard buffer A at a flow rate of 1 ml/min. PchA-containing fractions (4 ml) were pooled and stored at -80°C.

Analysis of Proteins-- Protein concentrations were determined by the method of Bradford (27) using a commercial reagent (Bio-Rad) and bovine serum albumin as the standard. The N-terminal sequence of PchA was determined by Dr. P. James (Eidgenössische Technische Hochschule, Zürich, Switzerland) on an Applied Biosystems peptide sequencer model 473A using Edman degradation. The subunit molecular mass of PchA was estimated by SDS-PAGE according to Lämmli and Favre (28) using the low molecular weight calibration kit from Amersham Biosciences as a standard. The molecular mass of native PchA was estimated by gel filtration chromatography on Sephadex G-150 (1.6 × 70 cm, 0.1 ml/min) and Bio-Gel P100 (1.6 × 70 cm, 0.1 ml/min) columns in buffer A with ribonuclease A (13.7 kDa), lysozyme (14.6 kDa), proteinase K (28.8 kDa), pepsin (34.5 kDa), protein A (42 kDa), ovalbumin (43 kDa), and bovine serum albumin (67 kDa) as markers. The elution volumes were plotted against the logarithm of molecular masses for the standards, and the linear regression curve was used to estimate the apparent molecular mass of PchA. The molecular mass of native PchA was also estimated from PAGE in non-denaturing gels of 7.5, 10, 12, 15, and 20% polyacrylamide, with the low molecular weight calibration kit from Amersham Biosciences as a standard, by Ferguson plot analysis (29). The slopes obtained from plots of the logarithm of relative mobility versus polyacrylamide concentration were plotted against the molecular mass values of the standard proteins.

Preparation of Antiserum and Western Immunoblot Procedure-- Rabbit polyclonal antibodies were generated by subcutaneous injection of about 410 µg of purified PchA and used in immunoblots as described (21).

Coupled ICS Assay-- Unless otherwise stated, the incubation mixture contained, in a final volume of 500 µl, 100 mM potassium phosphate buffer, pH 7.0, 10 mM MgCl2, 10% (v/v) glycerol, 1 mM DTT, 500 µM chorismate (purified by high pressure liquid chromatography), 48 units of purified PchB (corresponding to 3.7 µg) (21), and <=  2 units of PchA. One unit of enzyme activity is defined as the formation of 1 nmol of isochorismate (assayed as salicylate) per minute for ICS and isochorismate pyruvate-lyase. The reaction at 37 °C was initiated by the addition of chorismate to the enzyme solution and terminated after 5 min by the addition of 10 µl of concentrated HCl (10 M), followed by extraction with 3 ml of ethyl acetate. Blanks were obtained from non-incubated complete reaction mixtures. The product of the coupled enzymatic reaction, salicylate, was measured by its fluorescence using an excitation wavelength of 305 nm and an emission wavelength of 440 nm. The amount of salicylate formed was determined from a standard curve obtained with 0.5-8 µM salicylic acid in ethyl acetate. Assays for kinetic studies were performed in triplicate with 0.96 µg of purified PchA and 3.7 µg of PchB in standard incubation buffer with chorismate concentrations varying from 1 to 500 µM. The steady-state kinetic values did not vary by more than ± 10%. Initial velocity data were fitted to the equation of Hanes, using Enzpack software (Biosoft).

The influence of Mg2+ on the activity of PchA was studied in an incubation mixture containing 100 mM potassium phosphate pH 7.0, 1 mM DTT, and 10% glycerol (v/v). PchA (3.9 µg) was preincubated at 37 °C for 10 min. EDTA and MgCl2 were added at concentrations of 1 mM and 10 mM, respectively. The reaction was started by adding PchB (0.54 µg) and 100 µM chorismate and stopped after 5 min.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Purification of the PchA Enzyme-- ICS activity was measured in a coupled assay in the presence of an excess of PchB (typically ~30-fold with respect to units of enzyme activity). Thus, the isochorismate formed was converted quantitatively to salicylate during the incubation. Because the pchA gene is expressed only when the pchB gene is present in cis (14), we isolated PchA from P. aeruginosa ADD1976 carrying pME3359, which expresses both the pchBA genes from the T7 promoter (Fig. 2), according to the purification scheme described under "Experimental Procedures."


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Expression constructs for pchA. Plasmid pME3359 has been described previously (14). Plasmid pME3395 was constructed by introducing a deletion (Delta ) of a 21-bp RsaI fragment within pchB. PT7, vector promoter for T7 RNA polymerase; Ptac, LacIQ-repressed promoter for host RNA polymerase; R, RsaI site; X, XhoI site; S, SalI site.

PchA was purified to apparent homogeneity with 58% yield by three chromatographic steps (Table I). SDS-PAGE of the fraction obtained after the final MonoQ chromatography step indicated a >=  98% pure protein of about 50 kDa (data not shown). This subunit molecular mass is in good agreement with that (52.1 kDa) calculated from the deduced sequence of 476 amino acids residues (14). The N-terminal amino acid sequence of the PchA polypeptide (Ser-Arg-Leu-Ala-Pro-Leu-Ser-Gln) obtained by Edman degradation matched that predicted from sequence data (14) and indicates cleavage of the N-terminal methionine.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of the PchA enzyme from P. aeruginosa ADD1976/pME3359
Data shown are taken from a typical preparation. In three independent experiments, the reproducibility of the purification factors was ± 10%.

During PchA purification PchB activity was also followed, as there had been some previous speculation that PchA and PchB might form an enzymatic complex (14). However, during the first chromatographic step on DEAE-Sepharose, PchA was eluted after and well separated from PchB. Moreover, gel filtration of crude extracts on Bio-Gel P100 did not reveal any association of PchA and PchB (data not shown).

Molecular Mass of the Native PchA Enzyme-- This was estimated by gel exclusion chromatography on Sephadex G-150 and Bio-Gel P100 and by native PAGE at varying polyacrylamide concentrations. The molecular masses of 48 ± 2, 50 ± 2, and 50 ± 2 obtained by the three methods, respectively, indicate that the enzyme exists as a monomer.

Kinetic Properties of PchA-- Like the entC and menF isoenzymes having ICS activity in Escherichia coli (30, 31), the PchA enzyme of P. aeruginosa strictly depended on the presence of Mg2+. The PchA enzyme, pretreated with 1 mM EDTA and incubated in an incubation mixture without Mg2+, was inactive (<=  1.1% activity). The addition of 10 mM MgCl2 restored activity (data not shown). PchA showed hyperbolic saturation kinetics with its substrate, chorismate, with an apparent Km = 4.5 ± 0.5 µM and a kcat = 43.1 ± 4.9 min-1. Optimal activity was observed at pH 7.0 (data not shown). The chorismate-isochorismate interconversion catalyzed by PchA was reversible; incubation of PchA with isochorismate yielded chorismate (Fig. 3). Reversibility has also been observed for both ICSs of E. coli (30, 32).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Reversibility of the reaction catalyzed by PchA. Purified PchA (1 µg) from P. aeruginosa was incubated with 200 µM isochorismate in 100 mM potassium phosphate, pH 7.0, containing 10 mM MgCl2, 10% (v/v) glycerol, and 1 mM DTT. The reaction was stopped after 10 min () by the addition of 10 µl concentrated HCl, followed by extraction with ethyl acetate. In the control (- - -), the enzyme was omitted. After evaporation of the organic phase, the dry residue was dissolved in 100 µl 50% (v/v) acetonitrile and 0.43% (w/v) H3PO4. A 20-µl aliquot was injected into a Hewlett-Packard 1050 series LC system. Elution of the Nucleosil C-18 column (4 × 250 mm) at 1 ml/min was carried out with a linear gradient consisting of solvent A (0.43% (w/v) H3PO4) and solvent B (95% (v/v) acetonitrile in 0.43% (w/v) H3PO4), whereby solvent B increased from 7% (v/v) at 0 min to 54% (v/v) at 15 min. Compounds were identified by their retention times (established with synthetic compounds) and UV spectra. Isochorismate and chorismate were eluted at 8.7 and 11.2 min, respectively.

We tested a range of potential effectors of PchA. However, <10% inhibition or activation of ICS activity was found under standard assay conditions after the addition of either the end product pyochelin (100 µM), the pathway intermediates salicylate (10 µM) or dihydroaeruginoate (Dha in Fig. 1) (100 µM), and the aromatic amino acids tryptophan (100 µM), tyrosine (100 µM) or phenylalanine (100 µM). Furthermore, the addition of Fe2+ (100 µM) or cysteine (200 µM) did not significantly alter ICS activity. Thus, there is no evidence that aromatic amino acids or metabolites of the pyochelin pathway in P. aeruginosa (Fig. 1) can regulate the activity of the PchA enzyme.

PchA Concentration Limits the Rate of Salicylate Formation in Vitro-- To determine the rate-limiting factor in salicylate production, we prepared a crude extract from PAO1 wild type cells grown under iron limitation. A sample of this extract containing ~150 ng of PchA and ~100 ng of PchB, as judged by Western blots (data not shown) per 290 µg of total cellular protein, was incubated in the presence of 100 µM chorismate in 500 µl of incubation buffer. Under these conditions, the formation of salicylate was limited by the PchA concentration in the extract (Fig. 4). This could be seen when an excess (500 ng) of purified PchA was added; thereby, the rate of salicylate synthesis was increased ~3-fold and the transient time, i.e. the lag before steady state conditions were reached in the coupled enzyme reaction, was shortened from 1.5 min to <0.1 min (Fig. 4). This reduction of the transient time illustrates the fact that added PchA enhances the availability of the intermediate isochorismate to the second enzyme in the extract, PchB. By contrast, the addition of 500 ng of purified PchB did not enhance the capacity of the extract to synthesize salicylate (Fig. 4). These results indicate that in a crude P. aeruginosa PAO1 extract the activity of the first enzyme of the pathway, i.e. the synthesis of isochorismate, limits the rate of salicylate production.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Salicylate formation in cell extract from strain PAO1. Crude extract was prepared by sonication from strain PAO1 grown under iron limitation in GGP medium (33) to 2.1 × 109cells/ml. The incubation mixture (500 µl) contained 290 µg of protein from this extract in 100 mM potassium phosphate, pH 7.0, containing 10 mM MgCl2, 10% (v/v) glycerol, 1 mM DTT, and 100 µM chorismate. + PchA, addition of 0.5 µg purified PchA; + PchB, addition of 0.5 µg purified PchB. The reaction was started by addition of the substrate and carried out at room temperature. Salicylate formation was monitored continuously in a luminescence spectrometer at 440 nm using an excitation wavelength of 305 nm.

PchA Concentration Limits the Production of Salicylate and Pyochelin in Vivo-- To test the role of the first enzyme in salicylate formation and to see how salicylate availability influences the productivity of the pyochelin pathway, we constructed the pchA overexpression plasmid pME3395 (Fig. 2) in which the pchBA genes were fused to the inducible tac promoter (Ptac), and the pchB function was inactivated by an in-frame deletion, removing notably the codon for the essential Ile-88 residue of isochorismate pyruvate-lyase (21). We verified that in vivo the internally truncated PchB protein was totally devoid of isochorismate pyruvate-lyase activity. The mutated protein also lacked chorismate mutase activity (data not shown), the second PchB function (21). Using this somewhat unconventional construct, we overcame the problem that the pchA open reading frame cannot be expressed alone, even when it is equipped with a strong promoter and a good ribosome binding site (14).

Salicylate, Dha, and pyochelin were measured in cultures of the wild type PAO1, with or without the Ptac pchA overexpression construct pME3395. The growth medium used (GGP) contains glycerol and proteose peptone and favors pyochelin production because of limited iron availability (16, 33). Proteose peptone, a milk fraction containing mostly casein cleavage products, is a rich source of amino acids with the notable exception of cysteine, which is underrepresented (34). We therefore also conducted a series of experiments using GGP medium amended with 2 mM L-cysteine. In both media, pchA overexpression driven by the addition of the inducer IPTG caused strong salicylate accumulation and pyochelin overproduction during stationary phase, concomitant with the increased accumulation of Dha (Table II). During late exponential phase, the addition of 2 mM L-cysteine significantly enhanced the conversion of salicylate to pyochelin; however, irrespective of cysteine addition, pyochelin concentrations were consistently increased by pchA overexpression in comparison with wild type cultures (Table II).


                              
View this table:
[in this window]
[in a new window]
 
Table II
Effects of PchA overexpression on the in vivo synthesis of salicylate, Dha, and pyochelin by P. aeruginosa

PchA induction by IPTG was monitored in parallel by Western blot analysis and showed the expected expression pattern (Fig. 5A). The amount of PchB protein was also followed by Western blots; there was no indication of the chromosomally encoded PchB protein being overexpressed during pchA induction (data not shown). In another control experiment we confirmed that the addition of excess iron to the growth medium completely abolished the expression of the chromosomal pchA gene in strain PAO1 (Fig. 5B).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Immunoblot analysis of PchA. A, samples were taken from cultures of PAO1, PAO1/pME3395, and PAO1/pME3395 (induced with IPTG) grown as described in Table II. 109 cells were lysed in 50 µl of 10 mM Tris-HCl, pH 8.0, containing 1 mM EDTA, 2.5% (w/v) SDS, and 5% (w/v) beta -mercaptoethanol, and one-twentieth of this lysate was separated by SDS-PAGE on a 12.5% gel. Western blot analysis using a polyclonal anti-PchA antiserum was carried out as described (25). PchA, 50 ng of purified PchA. B, total cellular protein (12 µg) from strain PAO1 grown in GGP medium (33) without or with 100 µM FeCl3 was electrophoresed and subjected to immunoblotting as above. PchA, 100 ng of purified PchA.

From these results we conclude the following. (i) The intracellular concentration of PchA determines the rate of salicylate production both in vivo and in vitro. (ii) PchA concentration also determines the flux to pyochelin, and this effect is seen whether or not the medium contains an extra supply of the cosubstrate L-cysteine. (iii) Excess iron brings the expression of PchA (and the other enzymes of the pathway as well) to a halt by Fur-mediated repression of the pchDCBA and pchEFGHI operons (15, 16).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Using the siderophore pyochelin of P. aeruginosa as an example, we have addressed the question of where the bottleneck lies in a bacterial biosynthetic pathway leading to extracellular products. Clearly, the classical pattern, i.e. feedback inhibition and repression by the end product, is not observed here. Instead, we propose that the concentration of the first, non-allosteric enzyme, ICS, is one key determinant controlling the productivity of the pyochelin pathway (Table II). A similar observation has been made in filamentous fungi where penicillin production is critically dependent on the amount of the first enzyme, delta -(L-alpha -aminoadipyl)-L-cysteinyl-D-valine synthetase (35). Furthermore, in Streptomyces clavuligerus the reaction catalyzed by this enzyme is a rate-limiting step in cephalosporin biosynthesis (36). However, in other bacterial pathways producing extracellular compounds, the rate-limiting steps have rarely (if ever) been investigated.

In its native context, the pchA gene is placed last in the pchDCBA operon, which encodes, in this order, a salicylate-activating enzyme (22), a thioesterase of unknown function (15), isochorismate pyruvate-lyase (21), and ICS (Ref. 14, and this study). The promoter of this operon is positively controlled by the PchR protein in the presence of pyochelin (16) and negatively by the Fur repressor in the presence of iron (15). Within the operon, the expression of the pchDC and pchBA genes is tightly coordinated at a post-transcriptional level (14). Thus, iron availability and pyochelin acting as an autoinducer are two major signals that determine the productivity of the pathway by regulating pchA expression.

The high affinity of PchA for chorismate (Km = 4.5 µM) enables this enzyme to draw effectively on the chorismate pool in competition with the other enzymes of aromatic metabolism in P. aeruginosa (Fig. 1). In strain PAO1/pME3395, maximizing PchA expression by IPTG addition caused no measurable reduction in exponential growth rate and growth yield (data not shown), suggesting that maximal pyochelin synthesis does not seriously deplete the chorismate resources.

The data of Table II also show that cysteine availability in the growth medium improves the conversion of salicylate to pyochelin during growth and enhances the yield of pyochelin, especially in the stationary phase. Similar observations have recently been reported for another strain of P. aeruginosa (37). It is not known, however, whether there are regulatory links between pyochelin and cysteine synthesis in P. aeruginosa.

A multiple sequence alignment (Fig. 6) (38) places PchA of P. aeruginosa in a family of a dozen microbial ICSs that are currently known. As noted previously (14), the TrpE component of anthranilate synthase and the PabB component of the aminodeoxychorismate synthase of various microorganisms show significant sequence identities with PchA, essentially because of a shared chorismate binding domain (39, 40). However, the members of the ICS family do not intermingle with the PabB and TrpE families, contrary to the intrusion of the PabB of Bacillus subtilis into the TrpE cluster (Fig. 6, left side). The ICS tree constructed by sequence alignment (Fig. 6, right side) has strictly no resemblance with phylogenetic trees based on a sequence comparison of 16 S rRNAs or housekeeping proteins (41), suggesting that the ICS genes have traveled widely in the microbial world. This idea is supported by the finding that the irp-9 and ybtS genes, which are required for yersiniabactin biosynthesis, are part of mobile pathogenicity islands (42). Other ICS genes might also be part of pathogenicity islands and, as such, are transmissible between different bacteria.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6.   Sequence comparison of ICS, anthranilate synthase (TrpE), and p-aminobenzoate synthase (PabB). Sequences were aligned using ClustalW (38). All currently known ICSs of bacteria are shown, whereas only selected examples of TrpE and PabB sequences are represented. Accession number (protein identification number given by the NCBI) and strain are given in parenthesis. PchA (S58229, P. aeruginosa); VibC (NP_230422, Vibrio cholerae); DhbC (NP_391079, B. subtilis); PmsC (CAA70528, Pseudomonas fluorescens); EntC (AAB40793, Escherichia coli); AmoA (P23300, Aeromonas hydrophila); MenF (NP_390961, B. subtilis); MenF (NP_231610, V. cholerae); MenF (P38051, E. coli); MbtI (NP_216902; M. tuberculosis); Irp-9 (CAB46570, Y. enterocolitica); YbtS (NP_405477, Y. pestis); TrpE (NP_230819, V. cholerae); TrpE (NP_415780, E. coli); TrpE (NP_405749, Y. pestis); TrpE (NP_390149, B. subtilis); TrpE (NP_249300, P. aeruginosa); TrpE (NP_216125, M. tuberculosis); PabB (NP_387955, B. subtilis); PabB (NP_405340, Y. pestis); PabB (NP_416326, E. coli); PabB (NP_215521, M. tuberculosis).

It has been speculated that MbtI of Mycobacterium tuberculosis, YbtS of Yersinia pestis, and Irp-9 of Yersinia enterocolitica, which are peripheral ICS family members (Fig. 6) and are slightly smaller proteins than PchA, might carry out the direct conversion of chorismate to salicylate, basically because in these organisms no pchB homolog has been found in the vicinity of the ICS genes (43, 44). We have examined the purified P. aeruginosa ICS for its ability to produce salicylate but found no evidence for such a reaction in vitro (Fig. 3). In vivo, PchA did not have salicylate synthase activity either, as an entC mutant of E. coli carrying pME3395 (pchA+) was unable to produce salicylate, whereas the same strain carrying pME3368 (pchAB+) did (14). If the MbtI, YbtS, and Irp-9 proteins catalyzed just the chorismate-to-isochorismate conversion, another explanation should be sought. We found that the PchB enzyme of P. aeruginosa is structurally and perhaps also functionally related to chorismate mutase (21). It is therefore conceivable that in Yersinia and Mycobacterium spp. the isochorismate pyruvate-lyase reaction might be executed by a chorismate mutase. A similar situation may possibly also occur in Arabidopsis thaliana, where a PchA-like enzyme but no PchB homolog has been found (40).

    ACKNOWLEDGEMENTS

We thank L. Rindisbacher for help with antibody preparation and E.W. Leistner for a gift of isochorismate.

    FOOTNOTES

* This work was supported by Swiss National Foundation for Scientific Research Grant 31-56608.99.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 41-21-692-56-31; Fax: 41-21-692-56-35; E-mail: Dieter.Haas@imf.unil.ch.

Published, JBC Papers in Press, March 6, 2003, DOI 10.1074/jbc.M212324200

    ABBREVIATIONS

The abbreviations used are: ICS, isochorismate synthase; Dha, dihydroaeruginoate; DTT, dithiothreitol; IPTG, isopropyl-beta -D- thiogalactopyranoside.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Madigan, M. T., Martinko, J. M., and Parker, J. (2000) Brock Biology of Microorganisms , 9th Ed. , pp. 212-235, Prentice-Hall, Inc., Upper Saddle River, NJ
2. Winkler, M. E. (1996) Escherichia coli and Salmonella, Cellular and Molecular Biology , pp. 485-505, ASM Press, Washington, D. C.
3. Haas, D., Kurer, V., and Leisinger, T. (1972) Eur. J. Biochem. 31, 290-295[Medline] [Order article via Infotrieve]
4. Haas, D., and Leisinger, T. (1975) Eur. J. Biochem. 52, 377-383[Abstract]
5. Park, S. M., Lu, C. D., and Abdelal, A. T. (1997) J. Bacteriol. 179, 5309-5317[Abstract]
6. Calhoun, D. H., Pierson, D. L., and Jensen, R. A. (1973) Mol. Gen. Genet. 121, 117-132[Medline] [Order article via Infotrieve]
7. Patel, N., Pierson, D. L., and Jensen, R. A. (1977) J. Biol. Chem. 252, 5839-5846[Medline] [Order article via Infotrieve]
8. Whitaker, R. J., Gaines, C. G., and Jensen, R. A. (1982) J. Biol. Chem. 257, 13550-13556[Abstract/Free Full Text]
9. Fiske, M. J., Whitaker, R. J., and Jensen, R. A. (1983) J. Bacteriol. 154, 623-631[Medline] [Order article via Infotrieve]
10. Calhoun, D. H., Bonner, C. A., Gu, W., Xie, G., and Jensen, R. A. (2001) Genome Biol. 2, 30.1-30.16
11. Gosset, G., Bonner, C. A., and Jensen, R. A. (2001) J. Bacteriol. 183, 4061-4070[Abstract/Free Full Text]
12. Cox, C. D., Rinehart, K., Jr., Moore, M. L., and Cook, J., Jr. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 4256-4260[Abstract]
13. Ankenbauer, R. G., Toyokuni, T., Staley, A., Rinehart, K. L., and Cox, C. D. (1988) J. Bacteriol. 170, 5344-5351[Medline] [Order article via Infotrieve]
14. Serino, L., Reimmann, C., Baur, H., Beyeler, M., Visca, P., and Haas, D. (1995) Mol. Gen. Genet. 249, 217-228[Medline] [Order article via Infotrieve]
15. Serino, L., Reimmann, C., Visca, P., Beyeler, M., Della Chiesa, V., and Haas, D. (1997) J. Bacteriol. 179, 248-257[Abstract]
16. Reimmann, C., Serino, L., Beyeler, M., and Haas, D. (1998) Microbiology 144, 3135-3148[Abstract]
17. Heinrichs, D. E., and Poole, K. (1993) J. Bacteriol. 175, 5882-5889[Abstract]
18. Reimmann, C., Patel, H. M., Serino, L., Barone, M., Walsh, C. T., and Haas, D. (2001) J. Bacteriol. 183, 813-820[Abstract/Free Full Text]
19. Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., and Vasil, M. L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 7072-7077[Abstract/Free Full Text]
20. Barton, H. A., Johnson, Z., Cox, C. D., Vasil, A. I., and Vasil, M. L. (1996) Mol. Microbiol. 21, 1005-1017
21. Gaille, C., Kast, P., and Haas, D. (2002) J. Biol. Chem. 277, 21768-21775[Abstract/Free Full Text]
22. Quadri, L. E., Keating, T. A., Patel, H. M., and Walsh, C. T. (1999) Biochemistry 38, 14941-14954[CrossRef][Medline] [Order article via Infotrieve]
23. Dosselaere, F., and Vanderleyden, J. (2001) Crit. Rev. Microbiol. 27, 75-131[Medline] [Order article via Infotrieve]
24. McDonald, M., Mavrodi, D. V., Thomashow, L. S., and Floss, H. G. (2001) J. Am. Chem. Soc. 123, 9459-9460[CrossRef][Medline] [Order article via Infotrieve]
25. Brunschwig, E., and Darzins, A. (1992) Gene 111, 35-41[CrossRef][Medline] [Order article via Infotrieve]
26. Grisostomi, C., Kast, P., Pulido, R., Huynh, J., and Hilvert, D. (1997) Bioorg. Chem. 25, 297-305[CrossRef]
27. Bradford, M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
28. Lämmli, U. K., and Favre, M. (1973) J. Mol. Biol. 80, 575-599[Medline] [Order article via Infotrieve]
29. Tietz, D., and Chrambach, A. (1987) Anal. Biochem. 161, 395-411[Medline] [Order article via Infotrieve]
30. Liu, J., Quinn, N., Berchtold, G. A., and Walsh, C. T. (1990) Biochemistry 29, 1417-1425[Medline] [Order article via Infotrieve]
31. Daruwala, R., Bhattacharyya, D. K., Kwon, O., and Meganathan, R. (1997) J. Bacteriol. 179, 3133-3138[Abstract]
32. Dahm, C., Müller, R., Schulte, G., Schmidt, K., and Leistner, E. (1998) Biochim. Biophys. Acta 1425, 377-386[Medline] [Order article via Infotrieve]
33. Carmi, R., Varmeli, S., Levy, E., and Gough, F. G. (1994) J. Nat. Prod. 57, 1200-1205[Medline] [Order article via Infotrieve]
34. Steele, B. F., Sauberlich, H. E., Reynolds, M. S., and Baumann, C. A. (1949) J. Biol. Chem. 177, 533-544[Free Full Text]
35. Kennedy, J., and Turner, G. (1996) Mol. Gen. Genet. 253, 189-197[CrossRef][Medline] [Order article via Infotrieve]
36. Khetan, A., Malmberg, L. H., Sherman, D. H., and Hu, W. S. (1996) Ann. N. Y. Acad. Sci. 782, 17-24[Abstract]
37. Audenaert, K., Pattery, T., Cornelis, P., and Höfte, M. (2002) Mol. Plant-Microbe Interact. 15, 1147-1156[Medline] [Order article via Infotrieve]
38. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4690[Abstract]
39. Wang, Y., Addess, K. J., Geer, L., Madej, T., Marchler-Bauer, A., Zimmerman, D., and Bryant, S. H. (2000) Nucleic Acids Res. 28, 243-245[Abstract/Free Full Text]
40. Wildermuth, M. C., Dewdney, J., Wu, G., and Ausubel, F. M. (2001) Nature 414, 562-565[CrossRef][Medline] [Order article via Infotrieve]
41. Ludwig, W., and Schleifer, K.-H. (1999) ASM News 65, 752-757
42. Brem, D., Pelludat, C., Rakin, A., Jacobi, C. A., and Heesemann, J. (2001) Microbiology 147, 1115-1127[Abstract/Free Full Text]
43. Gehring, A. M., DeMoll, E., Fetherstone, J. D., Mori, I., Mayhew, G. F., Blattner, F. R., and Walsh, C. T. (1998) Chem. Biol. 5, 573-586[Medline] [Order article via Infotrieve]
44. Quadri, L. E., Sello, J., Keating, T. A., Weinreb, P. H., and Walsh, C. T. (1998) Chem. Biol. 5, 631-645[Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.